The global market for
lyophilisation is projected to be worth $3.26bn in 2015, spurred by the strong growth of new drugs and efforts to increase clinical approval.
Lyophilisation is an established method in the formulation of biological products, and an invaluable tool for prolonging shelf life and stability for biological drugs and vaccines.
As under met needs in drug transport and long term storage continues to prevail, robust lyophilisation methods outlined in PAT and QbD principles as well as alternative technologies will continue to experience strong demand.
This conference will focus on the scale- up efforts in the pharmaceutical industry with key topics in:
- PAT
- Quality by Design
- Vaccines
- Biological drugs
- Spray drying
In addition, a panel discussion on both days will focus on sale up and engineering issues, highlight new areas of innovation and debate whether small scale results in the laboratory provide realistic results in commercial scale up.
Benefits of Attending
This year’s event will feature spotlight presentations on:
- Innovative engineering techniques for building a robust scale up system;
- Implementation of PAT and QbD principles in industry and where it falls short
- Applications in therapuetic areas including vaccines, biologics and monoclonal antibodies.
Plus two panel discussions on both days for an engaging session between academia and pharma.
- Understand how to impliment PAT and QbD to gain the maximum benefits
- Discover the latest computational tools in use for predicting morphological changes during freeze drying
- Join the panel debate on where scale up falls short and whether small scale studies represent are too idealistic?
- Gain insight of some of the most important therapeutic drug classes using frezze drying technology and how they will perform in the next decade
Plus Two Half-Day Post-Conference Workshops | Wednesday 1st July 2015
A: Spray Dry and FormulationWorkshop leaders: Jim Bullock, Director, iFormulate Ltd
David York, School of Chemical and Process Engineering, University of Leeds
8.30am - 12.30pm
B: Defining and implementing QbD in the design space for Scale upWorkshop leader: Pierre Lebrun, Experienced Statistician - Project Leader, Arlenda
1.30pm - 5.30pm
Speakers
- Andrew Bayly, Chair in Chemical Engineering, Institute of Particle Science and Engineering, Leeds University
- Andrew Tait, Postgraduate Research Engineer, Newcastle University
- Bruce Williams, Chartered chemical and process engineer, Williams Process
- Daryl Williams, Reader in Particle Science, Imperial College London
- Daryl Williams, Director, Imperial College London
- Edith Norrant, Innovations Technology Sciences DirectorInnovations Technology Sciences Director, UCB Pharma
- Eunice Costa, Process Developement Engineer, Hovione Sociedade Quimica SA
- Jamshed Anwar, Associate Dean for Research & Professor of Computational Chemistry, Lancaster University
- Michael Dekner, Manager of Innovation, Baxter BioSciences
- Patrick Garidel, Process Sciences Department, Head of Pharmaceutical Basic Development, Boehringer-Ingelheim
- Pierre Lebrun, Associate Statistician - Project Leader, Arlenda
- Poul Bertelson, Principal Scientist, Takeda
- Yves Mayeresse, Director primary and secondary Expertise, GlaxoSmithKline
Please fill in your name and email to receive the conference agenda of this event.
The agenda is available as PDF under downloads at the right side of the page.
Venue
The venue is not yet available for this event.
Follow this event to be informed when the venue is available and stay informed on other changes.
Venue
Holiday Inn Regents ParkCarburton Street
London
W1W 5EE England
